<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="iso-abbrev">ACS Appl Bio Mater</journal-id><journal-id journal-id-type="publisher-id">mt</journal-id><journal-id journal-id-type="coden">aabmcb</journal-id><journal-title-group><journal-title>ACS Applied Bio Materials</journal-title></journal-title-group><issn pub-type="epub">2576-6422</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40219978</article-id><article-id pub-id-type="pmc">PMC12093379</article-id>
<article-id pub-id-type="doi">10.1021/acsabm.5c00144</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Enhanced Intracellular
IR780 Delivery by Acidity-Triggered
PEG-Detachable Hybrid Nanoparticles to Augment Photodynamic and Photothermal
Combination Therapy for Melanoma Treatment</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Tsai</surname><given-names>Min-Chen</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Hsiao</surname><given-names>Lun-Yuan</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Chang</surname><given-names>Yen-Hsuan</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Chen</surname><given-names>Yu-Hsin</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath5"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8965-3918</contrib-id><name><surname>Hu</surname><given-names>Shang-Hsiu</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Hung</surname><given-names>Chun-Yu</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath7"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2022-0858</contrib-id><name><surname>Chiang</surname><given-names>Wen-Hsuan</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Department
of Chemical Engineering, <institution>National Chung
Hsing University</institution>, Taichung 402, <country>Taiwan</country></aff><aff id="aff2"><label>&#x02021;</label>Department
of Biomedical Engineering and Environmental Sciences, <institution>National Tsing Hua University</institution>, Hsinchu 300, <country>Taiwan</country></aff><aff id="aff3"><label>&#x000a7;</label>Department
of Orthopedic Surgery, <institution>Jen-Ai Hospital</institution>, Taichung 402, <country>Taiwan</country></aff><aff id="aff4"><label>&#x02225;</label>i-Center
for Advanced Science and Technology (iCAST), <institution>National Chung Hsing University</institution>, Taichung 402, <country>Taiwan</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>whchiang@dragon.nchu.edu.tw</email>.</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>04</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>19</day><month>05</month><year>2025</year></pub-date><volume>8</volume><issue>5</issue><fpage>3995</fpage><lpage>4007</lpage><history><date date-type="received"><day>21</day><month>01</month><year>2025</year></date><date date-type="accepted"><day>04</day><month>04</month><year>2025</year></date><date date-type="rev-recd"><day>26</day><month>03</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0009" id="ab-tgr1"/></p><p>The PEGylation of
drug-carrying nanoparticles has often been used
to prolong blood circulation and improve drug deposition at tumor
sites. Nevertheless, the PEG-rich hydrophilic surfaces retard the
release of the payloads and internalization of therapeutic nanoparticles
by cancer cells, thus lowering the anticancer efficacy. To boost the
anticancer potency of the combined photodynamic therapy (PDT) and
photothermal therapy (PTT) against melanoma by conquering the PEG
dilemma, herein, the hybrid PEGylated chitosan-covered polydopamine
(PDA) nanoparticles (PCPNs) with acidity-elicited PEG detachment ability
were fabricated as carriers of IR780, a small-molecule photosensitizer
used for PTT and PDT. The IR780@PCPNs displayed a uniform, solid-like
spherical shape and sound colloidal stability. Under near-infrared
(NIR) irradiation, the IR780@PCPNs showed prominent photothermal conversion
efficiency (ca. 54.6%), robust photothermal stability, reduced IR780
photobleaching, sufficient singlet oxygen (<sup>1</sup>O<sub>2</sub>) production, and glutathione-depleting ability. Moreover, with the
environmental pH being reduced from 7.4 to 5.0 at 37 &#x000b0;C, the
decreased interactions between IR780 and PCPNs due to the increased
protonation of phenolic hydroxyl residues within PDA and primary amine
groups of chitosan accelerated the release of IR780 species from IR780@PCPNs.
Importantly, the cellular uptake of IR780@PCPNs by B16F10 melanoma
was remarkably promoted in a weakly acidic milieu upon PEG detachment
driven by the disintegration of acid-labile benzoic imine. With NIR
irradiation, the internalized IR780@PCPNs generated hyperthermia and <sup>1</sup>O<sub>2</sub> to damage mitochondria, thereby effectively
inhibiting the proliferation of B16F10 cells. Collectively, our findings
present a practical strategy for amplifying the anticancer efficacy
of PTT combined with PDT using PEG-detachable IR780@PCPNs.</p></abstract><kwd-group><kwd>PEG detachment</kwd><kwd>benzoic imine bond</kwd><kwd>IR780</kwd><kwd>photothermal and photodynamic therapy</kwd><kwd>melanoma
treatment</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>National Science and Technology Council</institution><institution-id institution-id-type="doi">10.13039/501100020950</institution-id></institution-wrap></funding-source><award-id>NSTC 113-2622-E-005-017; NSTC 113-2628-E-005-002 M</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>mt5c00144</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>mt5c00144</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Melanoma, an aggressive
form of skin cancer, develops from skin
melanocytes and is one of the most lethal diseases because of its
high metastasis and resistance to chemotherapy.<sup><xref ref-type="bibr" rid="ref1">1</xref>&#x02212;<xref ref-type="bibr" rid="ref3">3</xref></sup> Melanoma is
a rare tumor and less than 4% of skin cancer cases, but it accounts
for 80% of skin cancer deaths.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The treatment
of patients diagnosed with early-stage melanoma using tumor excision
and lymph node management is effective. Unfortunately, the five-year
survival rate for advanced melanoma is only 16% due to the low sensitivity
to traditional therapeutic modalities such as chemotherapy, radiotherapy,
immunotherapy, and targeted therapy.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref5">5</xref></sup> Therefore, photodynamic therapy (PDT) and photothermal
therapy (PTT) have emerged as new therapeutic tactics for melanoma
treatment.<sup><xref ref-type="bibr" rid="ref1">1</xref>&#x02212;<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>PDT has received much attention in melanoma treatment due
to its
advantages, including noninvasiveness, high spatiotemporal control,
low side effects, and convenience.<sup><xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref8">8</xref></sup> Through the photochemical
reaction of a photosensitizer excited with light of a specific wavelength
to convert oxygen molecules in tumor tissues to toxic reactive oxygen
species (ROS), PDT can induce tumor cell apoptosis and necrosis to
inhibit tumor growth. However, the hypoxia and strong glutathione
(GSH)-mediated antioxidant system of solid tumors largely limit the
antitumor effect of PDT.<sup><xref ref-type="bibr" rid="ref9">9</xref>&#x02212;<xref ref-type="bibr" rid="ref11">11</xref></sup> More studies demonstrate that
combining PDT with PTT is a viable approach to alleviate tumor hypoxia
upon PTT-mediated local blood circulation increase and oxygenation.<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref12">12</xref>&#x02212;<xref ref-type="bibr" rid="ref16">16</xref></sup> PTT relies on photosensitizers to transfer the absorbed light energy
to generate heat and cause local hyperthermia, thus ablating target
cancer cells.<sup><xref ref-type="bibr" rid="ref16">16</xref>&#x02212;<xref ref-type="bibr" rid="ref18">18</xref></sup> Recently, several commercial NIR dyes, including
indocyanine green (ICG), IR780, and IR820, have been considerably
used in PDT and PTT.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref20">20</xref></sup> Nevertheless, the poor water solubility, low photostability, insufficient
photothermal effect, and inadequate cellular internalization of free
photosensitizers have remarkably declined their clinical applications.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref21">21</xref></sup> To address these issues, various nanoparticles (e.g., liposomes,
polymer-based micelles, nanoassemblies, silica-based nanoparticles,
etc.) were fabricated as vehicles to realize the tumor-targeted delivery
of photosensitizers.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref22">22</xref>&#x02212;<xref ref-type="bibr" rid="ref26">26</xref></sup> For example, Tang&#x02019;s group fabricated IR780/lonidamine-carrying
liposomes to enhance the anticancer efficacy of PDT/PTT combination
therapy by inhibiting glycolysis to relieve tumor hypoxia.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> Furthermore, through coassembly of the amphiphilic
diblock copolymer poly(lactic-<italic>co</italic>-glycolic acid)-<italic>b</italic>-poly(ethylene glycol) (PLGA-<italic>b</italic>-PEG) and
electrostatic complexes comprising ICG molecules and branched poly(ethylenimine)
(PEI), the ICG-loaded hybrid polymeric nanomicelles (PNMs) were developed
by Jian and co-workers.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> The PNMs promoted
the optical stability of ICG, significantly reduced ICG leakage, and
enhanced intracellular ICG transport and photothermal cytotoxicity.
Shin&#x02019;s group developed PEGylated bovine serum albumin (BSA)-coated
silver core/shell nanoparticles to deliver ICG for enhancing photothermal
cancer therapy.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> In vitro studies showed
that PEG-BSA-AgNP/ICG promoted ICG photostability. As reported by
Li et al.,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> through the electrostatic,
&#x003c0;&#x02013;&#x003c0; stacking, and hydrophobic interactions, ICG
and epirubicin (EPI) coself-assembled into small molecular nanoparticles,
followed by surface coating with amphiphilic PEGylated lipid (1,2
distearoyl-<italic>sn</italic>-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene
glycol)-2000] (DSPE-PEG). The attained ICG-EPI nanoparticles exhibited
high dual-drug loading, good physiological stability, superior photothermal
response, pH-/photoresponsive drug release behavior, and promoted
cellular internalization compared with free ICG or EPI.</p><p>The
hydrophilic PEG-rich surfaces of most aforementioned nanoparticles
not only enhanced their colloidal stability but also prolonged blood
circulation via decreased capture by the reticuloendothelial system
(RES), thus promoting the deposition of nanoparticles in tumor sites
upon an enhanced permeability and retention (EPR) effect. In our previous
works,<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> to promote the colloidal stability of photothermal
polydopamine (PDA) nanoparticles, the PEGylated chitosan conjugates
were attained through the amidation of chitosan with PEG-COOH and
coated on the surfaces of the as-synthesized PDA nanoparticles. The
PEGylated chitosan-coated PDA nanoparticles were used as vehicles
for Fe<sup>3+</sup> and doxorubicin, respectively. Despite some advantages
described above, the PEGylation of nanoparticles has been demonstrated
to hinder the interaction of nanoparticles with target cancer cells,
reducing cellular uptake and intracellular drug delivery.<sup><xref ref-type="bibr" rid="ref31">31</xref>&#x02212;<xref ref-type="bibr" rid="ref35">35</xref></sup> This would impact the anticancer efficacy. To conquer the PEG dilemma,
in view of the weakly acidic microenvironment (pH<sub>e</sub> 6.3&#x02013;7.0)
and hypoxia of tumor tissues, some functionalized PEG-based materials
were decorated on the surfaces of the nanovehicles using the acid-labile
bonds (e.g., hydrazone, orthoester, and benzoic imine bonds) or hypoxia-responsive
bonds (e.g., azobenzene-4,4 &#x02032;-dicarboxylic acid),<sup><xref ref-type="bibr" rid="ref31">31</xref>&#x02212;<xref ref-type="bibr" rid="ref35">35</xref></sup> thus equipping these nanovehicles with tumor microenvironment-triggered
dePEGylation capability. Despite significant advancements in developing
nanoparticles with acidity- or hypoxia-triggered PEG detachment, most
were utilized to deliver chemotherapy reagents or nucleic acid drugs.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> For all we know, only a few studies have reported
using PEG-detachable nanoparticles to promote intracellular photosensitizer
delivery for melanoma treatment,<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> and
these nanoparticles transport only a single PDT or PTT with limited
anticancer potency.</p><p>Herein, we fabricated acidity-triggered
PEG-detachable hybrid nanoparticles
as carriers of IR780 to promote intracellular IR780 delivery for enhanced
PDT/PTT-based melanoma treatment (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). According to our previous work,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> as an essential component, the pH-responsive
PEGylated chitosan adducts were prepared by conjugating methoxy PEG
benzaldehyde (mPEG-CHO) with chitosan upon the acid-labile benzoic
imine. Notably, different from the aforementioned PEGylated chitosan
incapable of detaching PEG segments due to the lack of acidity-labile
linkage,<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref30">30</xref></sup> the PEGylated chitosan used in this study
could realize the PEG detachment by the acid-cleavable benzoic imine.
The hybrid PEGylated chitosan-coated PDA nanoparticles (PCPNs) were
attained by simultaneous oxidative self-polymerization of dopamine
molecules and the Michael addition of chitosan with PDA. Through the
&#x003c0;-&#x003c0; stacking, hydrophobic, and charge interactions of
IR780 molecules with PDA of PCPNs, the IR780-loaded PCPNs (IR780@PCPNs)
with a satisfactory drug loading content (8.8 wt %) were obtained.
The IR780@PCPNs exhibited a mean hydrodynamic diameter of ca. 166.9
nm and a solid-like spherical shape. The acid-induced disintegration
of the benzoic imine allowed PEG segment detachment from the surfaces
of IR780@PCPNs. Furthermore, the IR780 release from IR780@PCPNs was
remarkably accelerated in response to a pH reduction from 7.4 to 5.0.
Compared with free IR780 molecules, the IR780@PCPNs displayed superior
photothermal conversion efficiency, colloidal stability, and photothermal
stability. Also, IR780@PCPNs mediate depletion of GSH by the Michael
addition between PDA and GSH and show <sup>1</sup>O<sub>2</sub>-generating
capability under NIR laser irradiation. Remarkably, under a culture
environment of pH 6.5, imitating an acidic tumor microenvironment,
the internalization of IR780@PCPNs by B16F10 melanoma cells was efficiently
promoted via acidity-elicited dePEGylation. With NIR laser irradiation,
the endocytosed IR780@PCPNs generated hyperthermia and sufficient <sup>1</sup>O<sub>2</sub> to damage mitochondria, thus leading to cell
death (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>b).
In conclusion, the acid-triggered PEG detachment of IR780@PCPNs can
increase cellular uptake and boost PTT/PDT efficacy. This may provide
a meaningful reference for future clinical melanoma treatment.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Illustrative Diagram of (a) Fabrication of IR780@PCPNs and (b) Their
PTT/PDT-Based Anticancer Effect Enhanced by Acid-Activated PEG Detachment</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0008" id="gr1" position="float"/></fig></sec><sec id="sec2"><label>2</label><title>Materials
and Methods</title><sec id="sec2.1"><label>2.1</label><title>Materials</title><p>Dopamine&#x000b7;hydrochloride
(DA) was acquired from Alfa Aesar (USA). Chitosan oligosaccharide
(<italic>M</italic><sub>w</sub> 5.0 kDa, 81% degree of deacetylation)
was obtained from Glentham Life Science Ltd. (UK). IR780 iodide dye
(content 98%), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), glutathione (GSH), 2&#x02019;,7&#x02019;-dichlorodihydrofluorescein
diacetate (DCFH-DA), Dulbecco&#x02019;s modified Eagle&#x02019;s medium-high
glucose (DMEM), Hanks&#x02019; balanced salt solution (HBSS), and D<sub>2</sub>O (99.9 atom % D) were purchased from Sigma-Aldrich (USA).
1,3-diphenylisobenzofuran (DPBF) and 5,5&#x02032;-dithiobis (2-nitrobenzoic
acid) (DTNB) were purchased from Fluorochem (UK). Fetal bovine serum
(FBS) was obtained from Hyclone (USA). BODIPY 581/591 C11 was obtained
from Thermo Fisher Scientific (USA). B16F10 cells (murine melanoma
cells) and WS1 cells (human skin fibroblast cells) were acquired from
the Food Industry Research and Development Institute (Hsinchu City,
Taiwan).</p></sec><sec id="sec2.2"><label>2.2</label><title>Synthesis and Characterization of PEGylated
Chitosan Adducts</title><p>The synthesis of mPEG-CHO and PEGylated
chitosan and their characterization by FT-IR and <sup>1</sup>H NMR
were conducted based on the previously defined methodology.<sup><xref ref-type="bibr" rid="ref36">36</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> The PEGylated chitosan was prepared according to the synthetic route,
as revealed in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S1</ext-link>.</p></sec><sec id="sec2.3"><label>2.3</label><title>Fabrication of IR780@PCPNs</title><p>DA molecules
(2.5 mg) were dissolved in ethanol/deionized water cosolvent (0.8
mL). PEGylated chitosan adducts (6.0 mg) dissolved in tris buffer
(0.2 mL) were added dropwise to the DA solution. After being stirred
in the dark at 25 &#x000b0;C for 24 h, the resulting solution was dialyzed
(Biomate MWCO 12,000&#x0223c;14,000) against pH 8.0 phosphate buffer
at 4 &#x000b0;C to obtain the purified PCPNs. Subsequently, IR780 in
DMSO (2.0 mg/mL, 0.24 mL) was mixed with a PCPN-containing solution
at pH 8.0 (5 mg/mL, 0.96 mL), followed by stirring in the dark at
25 &#x000b0;C for 24 h. The IR780@PCPN solution was dialyzed (Biomate
MWCO 12,000&#x0223c;14,000) against pH 8.0 phosphate buffer to eliminate
unloaded IR780 molecules.</p></sec><sec id="sec2.4"><label>2.4</label><title>Characterization</title><p>The UV/vis spectra
of DA monomers, PDA particles, PCPNs, free IR780 molecules, or IR780@PCPNs
in pH 7.4 aqueous solutions were observed with a UV/vis spectrophotometer
(U2900, Hitachi, Japan). The particle size and zeta potential of PCPNs
and IR780@PCPNs in aqueous solutions were measured using a Litesizer
500 instrument (Anton Paar, USA). The structure analysis of PDA nanoparticles,
PEGylated chitosan adducts, and PCPNs was conducted by X-ray photoelectron
spectroscopy (XPS, PHI 5000 VersaProbe III X-ray photoelectron spectrometer.
The morphology of PCPNs and IR780@PCPNs was attained by transmission
electron microscopy (TEM) (JEM-1400 FLASH, JEOL, Japan) and scanning
electron microscopy (SEM) (JEOL JSM-7800F Prime Schottky Field Emission
SEM, Japan). The angle-dependent autocorrelation functions and mean-square
radius of gyration (<italic>R</italic><sub>g</sub>) of PCPNs and IR780@PCPNs
were attained by the dynamic and static light scattering (DLS/SLS)
measurements using a Brookhaven BI-200SM goniometer.</p></sec><sec id="sec2.5"><label>2.5</label><title>IR780 Loading Content and In Vitro IR780 Release</title><p>To
quantify the IR780 amount of IR780@PCPNs, 50 &#x003bc;L of the
IR780@PCPN solution before and after purification was diluted with
deionized water to 1.0 mL. Afterward, the IR780 absorbance of the
solutions at 780 nm was measured with a UV/vis spectrophotometer.
The loading efficiency (LE) and loading content (LC) of IR780 were
estimated as follows:<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_m001" position="anchor"/></disp-formula><disp-formula id="ueq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_m002" position="anchor"/></disp-formula></p><p>The in vitro IR780 dissolution test
was performed as follows: 1.0 mL of aqueous solution of IR780@PCPNs
was added to dialysis tubing (Biomate MWCO 12,000&#x02013;14,000) and
dialyzed against pH 7.4 and 6.5 PBS, and pH 5.0 acetate buffer (20
mL) at 37 &#x000b0;C, respectively. At the prescribed time intervals,
the inner sample was taken out to analyze the maximum IR780 absorbance
using the UV/vis spectrophotometer. Subsequently, the sample was returned
to the dialysis tube. The cumulative IR780 release (%) was calculated
based on the previously reported formula.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p></sec><sec id="sec2.6"><label>2.6</label><title>Photothermal Performance and Stability</title><p>The temperatures and infrared thermographic maps of aqueous solutions
with free IR780 molecules (22.2 &#x003bc;M), PCPNs (155 &#x003bc;g/mL),
or IR780@PCPNs (170 &#x003bc;g/mL) were recorded during 808 nm laser
irradiation (1.0 W/cm<sup>2</sup>) by using an infrared thermal imaging
camera (Thermo Shot F20, NEC, Germany). Moreover, the temperature
change of the above solutions during the cooling process was monitored.
The photothermal conversion efficiency (&#x003b7;) can be estimated
according to the formula previously reported elsewhere.<sup><xref ref-type="bibr" rid="ref38">38</xref>,<xref ref-type="bibr" rid="ref39">39</xref></sup> To assess the photothermal stability, aqueous solutions of free
IR780 molecules (22.2 &#x003bc;M), PCPNs (155 &#x003bc;g/mL), and IR780@PCPNs
(170 &#x003bc;g/mL) were irradiated repeatedly with an 808 nm laser
(1.0 W/cm<sup>2</sup>) for three cycles, each consisting of 5.0 min
of laser exposure followed by 7.0 min of no laser exposure. After
on/off laser irradiation each time, the absorption spectra of free
IR780 and IR780@PCPN solutions were obtained with a UV/vis spectrophotometer.
Also, the particle size of IR780@PCPNs before and after NIR laser
irradiation was determined by a Litesizer 500.</p></sec><sec id="sec2.7"><label>2.7</label><title><sup>1</sup>O<sub>2</sub> Generation and GSH
Consumption</title><p>DPBF assay was used to assess the NIR-triggered <sup>1</sup>O<sub>2</sub> production of IR780 molecules and IR780@PCPNs.
Free IR780 molecules and IR780@PCPNs (with an IR780 concentration
of 66 &#x003bc;M) in a DPBF solution (0.89 mM) were exposed to laser
irradiation (808 nm, 1.0 W/cm<sup>2</sup>) at different times, followed
by the analysis of the DPBF absorbance using a UV/vis spectrophotometer.
Moreover, the DPBF absorbance was normalized using the previously
reported method.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p><p>The GSH-depleting
ability of PCPNs and IR780@PCPNs was evaluated by a DTNB assay. The
PCPNs (400 &#x003bc;g/mL) and IR780@PCPNs (400 &#x003bc;g/mL) were each
suspended in 110 mL of a 1 mM GSH solution at 37 &#x000b0;C for 2, 6,
and 24 h, respectively, followed by centrifugation at 16,000 rpm for
10 min. A 0.9 mL aliquot of the supernatant was mixed with 0.1 mL
of 1 mM DTNB and the absorbance at 412 nm was determined by a UV/vis
spectrophotometer.</p></sec><sec id="sec2.8"><label>2.8</label><title>In Vitro Cellular Uptake</title><p>B16F10 cells
(1 &#x000d7; 10<sup>5</sup> cells/well) attached to 22 mm round glass
coverslips in six-well plates were incubated in DMEM containing 10%
FBS and 1% penicillin for 24 h. After the culture medium was discarded,
the cells were incubated with the fresh culture medium containing
free IR780 molecules at pH 7.4 or IR780@PCPNs at pH 7.4 and 6.5 (IR780
concentration: 2.5 &#x003bc;M) at 37 &#x000b0;C for 0.5 and 4 h. The fluorescence
images at 405 and 780 nm excitation wavelengths for Hoechst and IR780
were attained with a confocal laser scanning microscope (CLSM) (Olympus,
FluoView FV3000, Japan).</p></sec><sec id="sec2.9"><label>2.9</label><title>Intracellular <sup>1</sup>O<sub>2</sub> Generation</title><p>B16F10 cells (1 &#x000d7; 10<sup>5</sup> cells/well) attached to round
coverslips (22 mm) in 6-well plates were treated with PCPNs (17.4
&#x003bc;g/mL), free IR780 molecules, or IR780@PCPNs (IR780 concentration:
2.5 &#x003bc;M) at 37 &#x000b0;C and pH 7.4 or 6.5 for 4 h. Subsequently
removing the medium, the cells were exposed to irradiation of 808
nm NIR laser (0.5 W/cm<sup>2</sup>) for 2.5 min or not. After being
treated with DCFH-DA (5 &#x003bc;M) for 0.5 h, the cells were fixed
using 4% formaldehyde, followed by observation of cellular images
by fluorescence microscopy (ZEISS Axio Imager M2).</p></sec><sec id="sec2.10"><label>2.10</label><title>Mitochondrial Membrane Potential Examination</title><p>JC-1 staining
was employed to assess the mitochondrial function.
B16F10 cells (1 &#x000d7; 10<sup>5</sup>/well) in a 6-well plate were
cocultured with PCPNs (17.4 &#x003bc;g/mL), free IR780 molecules at
pH 7.4 or IR780@PCPNs (ICG concentration: 2.5 &#x003bc;M) at pH 7.4
and 6.5 for 4 h. After eliminating the medium, the cells were exposed
to irradiation of an 808 nm NIR laser (0.5 W/cm<sup>2</sup>) for 2.5
min or not, followed by treatment with JC-1 (2 &#x003bc;g/mL) at 37
&#x000b0;C for 30 min. Afterward, the cells were fixed using 4% formaldehyde
and observed by fluorescence microscopy. 485 and 535 nm excitation
wavelengths were used to observe JC-1 monomer and JC-1 aggregate fluorescence.
Moreover, the intracellular green fluorescence (JC-1 monomer) and
red fluorescence (JC-1 aggregate) were quantified by ImageJ 1.53t,
and the ratio of green and red fluorescence intensity was attained.</p></sec><sec id="sec2.11"><label>2.11</label><title>In Vitro Cytotoxicity</title><p>B16F10 cells
(1.0 &#x000d7; 10<sup>5</sup> cells/well) seeded in a 12-well plate were
incubated with free IR780 molecules, PCPNs, or IR780@PCPNs of different
concentrations at 37 &#x000b0;C and pH 7.4 or 6.5 for 4 h. After being
separated with trypsin-EDTA and centrifuged (1500 rpm), the cells
were collected and exposed to irradiation of an 808 nm laser (0.5
W/cm<sup>2</sup>) for 60 s or not. Then, the cells were redispersed
in 0.65 mL fresh medium and incubated for 24 h. The cell viability
was determined by MTT assay, as reported in our previous work.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> Furthermore, without NIR laser irradiation,
the viability of healthy WS1 cells incubated with different formulations
was assessed by a similar approach.</p></sec><sec id="sec2.12"><label>2.12</label><title>Statistics</title><p>Data were analyzed using
GraphPad Prism software version 5.01 and presented as mean &#x000b1;
standard deviation. Two-way ANOVA analysis was conducted to obtain
the differences of multiple groups. *<italic>p</italic> &#x0003c; 0.05,
**<italic>p</italic> &#x0003c; 0.01, ***<italic>p</italic> &#x0003c; 0.001 were
defined as significant differences.</p></sec></sec><sec id="sec3"><label>3</label><title>Results
and Discussion</title><sec id="sec3.1"><label>3.1</label><title>Synthesis and Characterization
of PEGylated
Chitosan Adducts</title><p>The PEGylated chitosan adducts were synthesized
through a Schiff base reaction between mPEG-CHO and chitosan (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S1</ext-link>). As revealed in the FT-IR spectrum
of PEGylated chitosan (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>a), the feature bands of C&#x02013;O, C&#x02013;C stretching
vibration from mPEG segments at 1105 and 955/841 cm<sup>&#x02013;1</sup> and C=N stretching vibration from imine linkages at 1650
cm<sup>&#x02013;1</sup>, respectively, and the disappearance of the
characteristic band of C=O stretching vibration at 1716 cm<sup>&#x02013;1</sup> from benzaldehyde groups of mPEG-CHO segments were
observed. Also, the absorption band of the N&#x02013;H/O-H and C&#x02013;H
from chitosan and mPEG at 3200&#x0223c;3600 and 2884 cm<sup>&#x02013;1</sup> was attained, respectively. Note that the full vanishment of the
aldehyde proton signals at &#x003b4; 10.1 ppm and the appearance of
the ethylene proton signals of mPEG at &#x003b4; 3.7 ppm and imine proton
at &#x003b4; 8.5 ppm and glucosamine proton of chitosan at &#x003b4; 2.8
ppm were obtained in the <sup>1</sup>H NMR spectrum of PEGylated chitosan
adducts (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>b).
These findings confirm that mPEG-CHO was efficiently conjugated with
chitosan by forming benzoic imine bonds. Based on the integral ratio
of the methoxy protons (&#x003b4; 3.4 ppm) of mPEG-CHO and the H2 protons
(&#x003b4; 2.8 ppm) from glucosamine groups of chitosan, the number
of mPEG chains for the one hundred glucosamine residues was calculated
to be approximately 9.4.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(a) FT-IR spectra of chitosan, mPEG-CHO, PEGylated
chitosan, PDA,
and PCPNs. (b) <sup>1</sup>H NMR spectra of chitosan, mPEG-CHO, and
PEGylated chitosan in D<sub>2</sub>O.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0001" id="gr2" position="float"/></fig></sec><sec id="sec3.2"><label>3.2</label><title>Fabrication and Characterization of IR780@PCPNs</title><p>To attain PCPNs as IR780 vehicles, the DA molecules were dissolved
in a PEGylated chitosan-containing aqueous solution and self-polymerized
via oxidation. As revealed in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>a, the DA molecules revealed only a feature absorption
peak at 281 nm, while the PCPNs showed appreciably increased absorption
from 300 to 900 nm, similar to bare PDA. Also, the PCPNs dispersed
in pH 7.4 PBS exhibited a monomodel size distribution (PDI: 0.21)
and an average hydrodynamic diameter of ca. 155.8 nm (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>b). By contrast, in the lack of PEGylated
chitosan adducts, the oxidative self-polymerization of DA molecules
tended to form large PDA particles, thus forming significant precipitates
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S2</ext-link>). These results suggest that
the PCPNs could be successfully prepared by one-pot codeposition of
DA molecules and PEGylated chitosan adducts and further stabilized
by hydrophilic PEGylated chitosan adducts. Compared to the XPS spectra
of PEGylated chitosan and PDA (<xref rid="fig2" ref-type="fig">Figures <xref rid="fig2" ref-type="fig">2</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">S3</ext-link>), the XPS spectrum
of PCPNs has the feature peaks of pyrrolic N (399.6 eV) and graphitic
N (402.1 eV) from PDA and of amine (399.4 eV), amide (399.7 eV) and
imine (398.2 eV) from PEGylated chitosan adducts (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>d). Based on these findings,
through the Michael addition between primary amine groups of chitosan
with 5,6-dihydroxyindole units of PDA, the PEGylated chitosan adducts
were effectively conjugated with PDA nanoparticles (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>a). Based on the TGA profiles
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S4</ext-link>), the PCPNs comprise approximately
74.1 wt % PEGylated chitosan and 25.9 wt % PDA. Moreover, the zeta
potential of PCPNs at pH 7.4, obtained to be around &#x02212;5 mV,
is distinct from that of the bare PDA nanoparticles (ca. &#x02212;28.5
mV) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>e). This
suggests that the hydrophilic PEGylated chitosan significantly shields
the negative charges from the phenolic hydroxyl groups of PDA.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>(a) UV/vis
absorption spectra of DA monomers, PDA particles, free
IR780 molecules, PCPNs, and IR780@PCPNs in pH 7.4 aqueous solution.
(b) Particle size distribution profiles of PCPNs and IR780@PCPNs dispersed
in pH 7.4 PBS. N 1s XPS spectra of (c) PEGylated chitosan adducts
and (d) PCPNs. (e) Zeta potential values of PDA particles, PCPNs,
and IR780@PCPNs at pH 7.4, 6.5, and 5.0. (f) Zeta potential values
of IR780@PCPNs in aqueous solutions at pH 7.4 and 5.0 at different
time intervals.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0002" id="gr3" position="float"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>DLS Data and IR780
Loading Capacities
of PCPNs and IR780@PCPNs</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">sample</th><th style="border:none;" align="center" char="&#x000b1;"><italic>D</italic><sub>h</sub> (nm)</th><th style="border:none;" align="center" char="&#x000b1;">PDI</th><th style="border:none;" align="center" char="&#x000b1;">LE (%)</th><th style="border:none;" align="center" char="&#x000b1;">LC (wt %)</th></tr></thead><tbody><tr><td style="border:none;" align="left">PCPNs</td><td style="border:none;" align="char" char="&#x000b1;">155.8&#x000a0;&#x000b1;&#x000a0;2.5</td><td style="border:none;" align="char" char="&#x000b1;">0.21&#x000a0;&#x000b1;&#x000a0;0.02</td><td style="border:none;" align="char" char="&#x000b1;">&#x000a0;</td><td style="border:none;" align="char" char="&#x000b1;">&#x000a0;</td></tr><tr><td style="border:none;" align="left">IR780@PCPNs</td><td style="border:none;" align="char" char="&#x000b1;">166.9 &#x000b1; 5.6</td><td style="border:none;" align="char" char="&#x000b1;">0.20 &#x000b1; 0.04</td><td style="border:none;" align="char" char="&#x000b1;">96.7&#x000a0;&#x000b1;&#x000a0;2.4</td><td style="border:none;" align="char" char="&#x000b1;">8.8&#x000a0;&#x000b1;&#x000a0;0.2</td></tr></tbody></table></table-wrap><p>SEM and TEM images showed that PCPNs exhibited a well-dispersed
spherical form (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>a). Note that the particle sizes of the PCPNs observed by SEM or
TEM were appreciably smaller than those determined by DLS due to their
structural transition from the dehydration (SEM or TEM) to hydration
(DLS) status. Also, a strong linear relationship between the relaxation
frequency (&#x00393;) and the square of the scattering vector (<italic>q</italic><sup>2</sup>) observed in the angle-dependent DLS data
of PCPNs in pH 7.4 PBS (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>b) indicates their spherical form in aqueous solution.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> Also, based on the <italic>R</italic><sub>g</sub> of PCPNs determined by SLS to be 61 nm (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S5</ext-link>), their <italic>R</italic><sub>g</sub>/<italic>R</italic><sub>h</sub> value was estimated to be ca. 0.79. Some previous studies
showed that the solid sphere-like nanoparticles from the self-assembly
of amphiphilic copolymers possessed an <italic>R</italic><sub>g</sub>/<italic>R</italic><sub>h</sub> value of 0.78.<sup><xref ref-type="bibr" rid="ref40">40</xref>,<xref ref-type="bibr" rid="ref41">41</xref></sup> Based on DLS/SLS data and TEM/SEM images, the PCPNs exhibited a
solid sphere-like shape consisting of a PDA core covered by PEGylated
chitosan (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>a).
Furthermore, it was observed that the PCPNs dispersed in pH 7.4 PBS
with or without 10% FBS at 37 &#x000b0;C maintained nearly unchanged
particle size over 24 h (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S6</ext-link>). These
findings illustrate that the hydrophilic PEGylated chitosan-rich surfaces
of PCPNs could promote their colloidal stability by preventing interparticle
aggregation and nonspecific protein adsorption.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>(a) SEM images of (i)
PCPNs and (iii) IR780@PCPNs. TEM images of
(ii) PCPNs and (iv) IR780@PCPNs. Scale bars: 200 nm. (b) Angle-dependent
DLS (black square) and SLS (blue circle) measurements performed on
IR780@PCPNs in pH 7.4 PBS. (c) Particle size distribution profiles
of IR780@PCPNs dispersed in 10% FBS-containing pH 7.4 PBS at various
intervals. (d) Cumulative IR780 release performance of IR780@PCPNs
in aqueous pH 7.4, 6.5, and 5.0 solutions at 37 &#x000b0;C.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0003" id="gr4" position="float"/></fig><p>Through the addition of IR780 molecules to the
PCPN solution,
IR780@PCPNs
were attained. As revealed in the UV/vis spectra (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>a), distinct from the PCPNs,
the IR780@PCPNs showed the feature IR780 absorption. Moreover, the
characteristic IR780 absorption of IR780@PCPNs remarkably shifted
from 779 to 786 nm, being ascribed to the incorporation of IR780 molecules
with PCPNs via the hydrophobic, &#x003c0;-&#x003c0; stacking, and charge
interactions between cationic IR780 and negatively charged PDA. Some
studies also reported a remarkable red shift in the IR780 absorption
of IR780-carrying PDA-rich nanocarriers.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref42">42</xref></sup> Notably, the IR780 loading efficiency and content of IR780@PCPNs
were determined to be ca. 96.7% and 8.8 wt % (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The mean hydrodynamic diameter of IR780@PCPNs
attained at ca. 166.9 nm is somewhat larger than that of the drug-free
PCPNs (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> and <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>b).</p><p>Importantly,
the IR780@PCPNs at pH 5.0 showed marked zeta potential
conversion from +5 to +15 mV with prolonged time from 5 to 60 min
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>f). Such an
acidity-elicited zeta potential variation of IR780@PCPNs could be
attributed to the following reasons. First, when the solution pH was
adjusted from 7.4 to 5.0, within 5 min, the zeta potential of IR780@PCPNs
was quickly converted from &#x02212;6.1 to +5 mV. Obviously, in addition
to the reduced dissociation of phenolic hydroxyl residues of the PDA
core, as evidenced by the decrease in surface negative charges (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>e), the primary amine
groups of chitosan segments rapidly protonated in an acidic environment,
thus leading to the increase in positive charges on the nanoparticle
surfaces. Subsequently, through the acid-induced disintegration of
benzoic imine of PEGylated chitosan, the PEG segments gradually detached
from the surfaces of IR780@PCPNs over time, leading to increased exposure
of positively charged chitosan. By contrast, the IR780@PCPNs at pH
7.4 maintained a nearly unchanged zeta potential (ca. &#x02212;6.1
mV) at the same intervals due to a bit of protonation of the chitosan
segments and PEG covering-induced charge shielding. Furthermore, no
significant size variation of IR780@PCPNs was attained in response
to a pH change from 7.4 to 5.0 over 48 h (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S7</ext-link>). This indicates that the IR780@PCPNs could retain stable
colloidal stability during acidity-triggered PEG detachment.</p><p>According to TEM and SEM images (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>a) and DLS/SLS data (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>b), the IR780@PCPNs have a well-dispersed
spherical solid-like conformation similar to PCPNs. By the hydrophilic
PEGylated chitosan surfaces, the IR780@PCPNs maintained robust colloidal
stability in pH 7.4 PBS with or without 10% FBS for 24 h (<xref rid="fig3" ref-type="fig">Figures <xref rid="fig3" ref-type="fig">3</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">S8</ext-link>). Notably, the IR780@PCPNs dispersed in pH
7.4 PBS remarkably declined IR780 premature leakage (below 20% within
6 h) compared to free IR780 molecules that quickly diffused across
the dialysis tube under the same condition (over 80% within 6 h) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>d). For IR780@PCPNs
at pH 7.4, the extensive hydrophobic, &#x003c0;&#x02013;&#x003c0; stacking,
and charge interactions between cationic IR780 and negatively charged
PDA could sufficiently hinder IR780 liberation. When the solution
pH was adjusted from 7.4 to 5.0, the level of cumulative IR780 liberation
from IR780@PCPNs was appreciably increased. This indicates that the
diminished interactions of PCPNs with IR780 molecules driven by acidity-induced
protonation of chitosan segments and phenolic hydroxyl groups from
PDA nanoparticles and dePEGylation could remarkably accelerate the
IR780 outflow from IR780@PCPNs. Such an acidity-activated IR780 release
was expected to enhance the NIR-triggered intracellular <sup>1</sup>O<sub>2</sub> production by increasing the contact of IR780 with
endogenous oxygen.</p></sec><sec id="sec3.3"><label>3.3</label><title>Photothermal Performance
and Stability of
IR780@PCPNs</title><p>As presented in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a, with NIR laser irradiation (1.0 W/cm<sup>2</sup> for 300 s), the temperature elevation of the IR780@PCPN solution
was much higher than that of aqueous solutions containing either free
IR780 molecules or PCPNs at the same IR780 and PCPN concentrations.
According to the photothermal heating&#x02013;cooling curve (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b,c), the photothermal
conversion efficiency (&#x003b7;) of IR780@PCPNs was calculated to be
54.6%, remarkably higher compared to that of IR780 molecules (11.7%)
and PCPNs (44.6%) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S9</ext-link>). Through
the inherent PDA-based photothermal property of PCPNs and the remarkable
red-shifted absorption of the encapsulated IR780 molecules, the IR780@PCPNs
displayed an enhanced NIR absorption capability and photothermal conversion
efficiency. It is worth highlighting that IR780@PCPNs showed a photothermal
conversion efficiency superior to other IR780-loaded nanoparticles
reported in previous studies.<sup><xref ref-type="bibr" rid="ref43">43</xref>&#x02212;<xref ref-type="bibr" rid="ref45">45</xref></sup> Moreover, during NIR laser radiation,
the elevation of the solution temperature was considerably amplified
with an increased IR780@PCPN concentration from 85 to 340 &#x003bc;g/mL
or enhanced laser power density from 0.5 to 1.25 W/cm<sup>2</sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S10</ext-link>). Notably, following three cycles
of NIR laser irradiation (on/off), compared to free IR780 molecules
with significantly reduced photothermal ability, the IR780@PCPNs still
maintained a nearly intact photothermal effect (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>d). On the other hand, after repeated NIR
laser irradiation, compared to the dramatic decline in the absorption
(600&#x02013;800 nm) of free IR780 molecules (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>e), the absorption of IR780@PCPNs was moderately
decreased, indicating the reduced photoinduced degradation degree
of IR780 encapsulated within PCPNs (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>f). Interestingly, the IR780@PCPNs exhibited
somewhat reduced IR780 absorbance post-repeated NIR irradiation but
nearly unchanged photothermal effect, although this mechanism is currently
unclear. Furthermore, the IR780@PCPNs remained virtually unchanged
in the particle size before and after laser irradiation (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S11</ext-link>). These findings signify that the
IR780@PCPNs have a prominent photothermal effect and stability, thus
showing promising application in the melanoma treatment of IR780-based
PTT and PDT.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>(a) Heating curves of IR780 molecules, PCPNs, and IR780@PCPNs
in
pH 7.4 PBS exposed to NIR laser irradiation. Photothermal performance
and plot fitting of cooling time versus the negative natural logarithm
of the driving force temperature during the cooling process of (b)
IR780@PCPN solution and (c) free IR780 molecules (IR780 concentration:
22.2 &#x003bc;M). (d) Photothermal performance test for aqueous solutions
of IR780 molecules, PCPNs, or IR780@PCPNs receiving three laser on/off
cycles (808 nm, 1.0 W/cm<sup>2</sup>). UV/vis spectra of (e) the IR780
solution and (f) the IR780@PCPN solution receiving repeated laser
irradiation. Inset: Photos of IR780 solution and IR780@PCPN solution
before and after the first laser on/off cycle (808 nm, 1.0 W/cm<sup>2</sup>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0004" id="gr5" position="float"/></fig></sec><sec id="sec3.4"><label>3.4</label><title><sup>1</sup>O<sub>2</sub> Production and GSH
Exhaustion of IR780@PCPNs</title><p>The ability of IR780@PCPNs to generate <sup>1</sup>O<sub>2</sub> upon NIR-triggering was evaluated by using DPBF,
a probe for <sup>1</sup>O<sub>2</sub>. After reacting with <sup>1</sup>O<sub>2</sub>, DPBF displayed a decline in absorption at around 410
nm. With 808 nm NIR laser irradiation (1.0 W/cm<sup>2</sup>), no significant
change in the absorbance of DPBF molecules in the PCPN solution was
attained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S12a</ext-link>). In contrast, with
irradiation time being prolonged from 2.5 to 10 min, the absorbance
of DPBF molecules in aqueous solutions of IR780@PCPNs or IR780 molecules
(IR780 concentration = 66 &#x003bc;M) was considerably reduced (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>a and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">S12b</ext-link>). The results suggest that the IR780@PCPNs
and free IR780 molecules can convert oxygen to <sup>1</sup>O<sub>2</sub> through the NIR-triggered IR780-based photodynamic effect. As presented
in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b, with
laser irradiation of 5 and 10 min, the DPBF in IR780 solution showed
appreciably lower normalized absorbance than DPBF in IR780@PCPN solution,
indicating that free IR780 molecules produced more <sup>1</sup>O<sub>2</sub> due to the effective contact of free IR780 molecules with
surrounding oxygen to perform photodynamic activation. Similar results
regarding the increased <sup>1</sup>O<sub>2</sub> production of free
photosensitizers were reported elsewhere.<sup><xref ref-type="bibr" rid="ref46">46</xref>,<xref ref-type="bibr" rid="ref47">47</xref></sup></p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>(a)
UV/vis absorption spectra of DPBF in IR780@PCPNs-containing
aqueous solution receiving 808 nm laser irradiation at different times.
(b) Normalized absorbance of DPBF in aqueous solutions of IR780, PCPNs,
and IR780@PCPNs, respectively, exposed to 808 nm laser irradiation
at different times. (c) UV/vis absorption spectra of DTNB in a GSH
solution treated with IR780@PCPNs for different time intervals. (d)
Residual content of GSH treated with PCPNs and IR780@PCPNs for various
time intervals.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0005" id="gr6" position="float"/></fig><p>Although <sup>1</sup>O<sub>2</sub>-mediated PDT
shows great potential
in clinical cancer treatment, the intracellular high GSH level leads
to significant scavenging of <sup>1</sup>O<sub>2</sub> to diminish
oxidative damage, thereby lowering the cytotoxicity of PDT. To address
this issue, combining the GSH-depleting functionalized nanoparticles
with PDT reagents is essential. Since PDA can eliminate GSH through
Michael addition,<sup><xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup> the GSH depletion capability
of IR780@PCPNs at 37 &#x000b0;C was evaluated by DTNB assay. Through
the thiol-exchange reaction between DTNB and GSH, 5-thio-2-nitrobenzoic
acid (TNB) was produced. As shown in <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">S13</ext-link>, in
the GSH aqueous solution pretreated with IR780@PCPNs or PCPNs, the
TNB absorbance at 412 nm gradually declined as the pretreatment time
was prolonged. This verifies that the PDA of PCPNs and IR780@PCPNs
could scavenge GSH by covalent coupling of quinone moieties from PDA
with thiol groups of GSH, thus reducing the amount of GSH reacted
with DTNB. Notably, after 24 h of pretreatment, the IR780@PCPN and
PCPN groups exhibited comparable residual GSH content (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>d), suggesting that the encapsulation
of IR780 molecules into PCPNs could not impact the GSH consumption
performance of PCPNs.</p></sec><sec id="sec3.5"><label>3.5</label><title>Cellular Uptake and Intracellular <sup>1</sup>O<sub>2</sub> Production</title><p>In order to investigate
the effect
of acidity-triggered dePEGylation on the cellular uptake of IR780@PCPNs,
their internalization by B16F10 cells was observed by CLSM. Free IR780
molecules were employed for comparison. As shown in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>a,b, when the coculture time
was prolonged from 0.5 to 4 h, the intracellular IR780 fluorescence
signals of B16F10 cells treated with IR780@PCPNs at pH 6.5 mimicking
a weakly acidic tumor microenvironment were appreciably enhanced compared
to those of cells receiving IR780@PCPNs at pH 7.4. This signifies
that the dePEGylation and positive charge exposure of IR780@PCPNs
upon acidity-activated hydrolysis of the benzoic imine bond and chitosan
protonation could enhance their affinity for B16F10 cells, thus increasing
their cellular uptake. Similar results regarding the boosted cellular
internalization of nanoparticles by stimuli-triggered dePEGylation
were also reported elsewhere.<sup><xref ref-type="bibr" rid="ref31">31</xref>&#x02212;<xref ref-type="bibr" rid="ref36">36</xref></sup> By contrast, in pH 7.4 culture medium, the outer PEG segments of
IR780@PCPNs markedly retarded their cellular internalization. Furthermore,
with 4 h incubation, B16F10 cells incubated with free IR780 molecules
showed remarkably lower IR780 fluorescence signals compared to those
of cells exposed to IR780@PCPNs at pH 6.5, being ascribed to the immense
aggregation of hydrophobic IR780 during the coculture process to hinder
the cellular internalization.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>(a) CLSM images and (b) intracellular mean IR780
fluorescence intensity
of B16F10 cells incubated with free IR780 molecules at pH 7.4 or IR780@PCPNs
at pH 7.4 or 6.5 for 0.5 and 4 h, respectively, at 37 &#x000b0;C (IR780
= 2.5 &#x003bc;M). Scale bars: 15 &#x003bc;m. (c) DCF fluorescence images
of B16F10 cells receiving different treatments. Scale bars: 50 &#x003bc;m.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0006" id="gr7" position="float"/></fig><p>Next, the DCFH-DA probe, a ROS indicator,<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> was utilized to assess the intracellular <sup>1</sup>O<sub>2</sub> production of B16F10 cells treated with free
IR780 molecules and
IR780@PCPNs, respectively. In the absence of NIR irradiation, B16F10
cells incubated with free IR780 molecules, PCPNs, or IR780@PCPNs showed
few DCF fluorescences (<xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>c), indicating the lack of intracellular <sup>1</sup>O<sub>2</sub>. With irradiation of the NIR laser, B16F10 cells receiving
IR780 molecules (IR780 concentration = 2.5 &#x003bc;M) showed remarkably
enhanced DCF fluorescence, illustrating the conversion of endogenous
oxygen to <sup>1</sup>O<sub>2</sub> via IR780-based photodynamic activity.
Importantly, exposed to NIR laser irradiation, B16F10 cells cocultured
with IR780@PCPNs at pH 6.5 displayed stronger DCF fluorescence signals
than cells receiving the counterpart at pH 7.4. Undoubtedly, the acid-triggered
PEG detachment of IR780@PCPNs can augment their uptake by B16F10 cells,
thereby efficiently increasing intracellular IR780 transport and generating
intracellular <sup>1</sup>O<sub>2</sub> by the IR780-mediated photodynamic
effect. In contrast, the lowered internalization of IR780@PCPNs by
B16F10 cells at pH 7.4 due to PEG interfering decreased intracellular
IR780 delivery, thereby reducing NIR-triggered <sup>1</sup>O<sub>2</sub> production. Furthermore, after laser irradiation, compared with
the B16F10 cells receiving IR780@PCPNs at pH 6.5, the IR780-treated
B16F10 cells showed somewhat higher DCF fluorescence intensity. This
could be attributed to that free IR780 molecules sufficiently converted
intracellular oxygen to <sup>1</sup>O<sub>2</sub>. In contrast, the
steric barriers of IR780@PCPNs partly limited the contact of IR780
molecules with oxygen, thereby decreasing the <sup>1</sup>O<sub>2</sub> production.</p></sec><sec id="sec3.6"><label>3.6</label><title>Mitochondria Damage and
In Vitro Anticancer
Potency</title><p>The mitochondrial damage has been reported to be
a vital and characteristic mark of ROS-involved apoptosis.<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> To investigate the effects of <sup>1</sup>O<sub>2</sub> generated
from IR780@PCPNs on the mitochondria of B16F10 cells, JC-1 was employed
to indicate mitochondrial membrane potential. JC-1 forms an aggregate
(in healthy mitochondria) with red fluorescence. As membrane potential
declines due to apoptosis, JC-1 becomes monomers, showing green fluorescence.<sup><xref ref-type="bibr" rid="ref51">51</xref>&#x02212;<xref ref-type="bibr" rid="ref53">53</xref></sup> Without laser irradiation, B16F10 cells cocultured with IR780 molecules,
PCPNs, or IR780@PCPNs exhibited strong red fluorescence and a low
ratio of green and red fluorescence intensity (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>a,b), indicating intact mitochondrial function.
Interestingly, with laser irradiation, a somewhat decreased red fluorescence
intensity and increased ratio of green and red fluorescence intensity
were observed in the PCPN-treated B16F10 cells, indicating mitochondria
destruction by NIR-triggered PCPN-based hyperthermia. Such a hyperthermia-elicited
functional disorder of the mitochondria in different cancer cell lines
was reported in other studies.<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup> Notably, with NIR laser
irradiation, B16F10 cells receiving IR780@PCPNs at pH 6.5 exhibited
significantly reduced red fluorescence signals and a prominent amplified
ratio of green and red fluorescence intensity compared to cells incubated
with IR780@PCPNs or PCPNs at pH 7.4. This suggests that the promoted
internalized IR780@PCPNs upon acidity-elicited dePEGylation could
remarkably damage mitochondria by NIR-triggered <sup>1</sup>O<sub>2</sub> generation and hyperthermia. Moreover, considering the short
diffusion distance and half-life of <sup>1</sup>O<sub>2</sub>, the
mitochondria-targeting capability of free IR780<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref></sup> and its better <sup>1</sup>O<sub>2</sub>-producing ability (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b), the acidity-activated
IR780 liberation of IR780@PCPNs was assumed to promote the targeting
of IR780 to mitochondria and augment the <sup>1</sup>O<sub>2</sub> generation and mitochondria damage (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>b).</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>(a) JC-1 staining images and (b) ratio of green
and red fluorescence
intensities of B16F10 cells subjected to different treatments. Scale
bars: 50 &#x003bc;m. Viability of B16F10 cells treated with PCPNs, IR780@PCPNs
at pH 7.4 or 6.5, or free IR780 molecules at pH 7.4 without laser
irradiation (c) or laser irradiation (d).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_0007" id="gr8" position="float"/></fig><p>To investigate the effect of acidity-triggered
dePEGylation of
IR780@PCPNs on their PDT/PTT-mediated anticancer capability, the viability
of B16F10 cells incubated with IR780@PCPNs at pH 7.4 or 6.5 and exposed
to laser irradiation was examined using the MTT test. As presented
in <xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>c, without
laser irradiation, B16F10 cells incubated with PCPNs (2.2&#x0223c;17.4
&#x003bc;g/mL), free IR780, or IR780@PCPNs (IR780 concentration of 0.34&#x0223c;2.5
&#x003bc;M) showed quite high cell viability (over 80%). As the IR780
concentration was increased to 5.0 &#x003bc;M, the viability of B16F10
cells treated with IR780@PCPNs or free IR780 somewhat declined to
below 80%, indicating a little cytotoxicity of IR780 on cancer cells.
In contrast, under laser irradiation, the viability of B16F10 cells
incubated with free IR780 molecules or IR780@PCPNs appreciably reduced
with increased IR780 concentration, while the viability of cells treated
with PCPNs slightly decreased as the concentration of PCPNs was increased
to 34.8 &#x003bc;g/mL (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>d). Based on these findings, compared to single PTT delivered
by PCPNs, the combined PTT and PDT based on free IR780 molecules or
IR780@PCPNs displayed a prominent anticancer effect on B16F10 cells.
Notably, with the culture milieu pH being changed from 7.4 to 6.5,
the viability of IR780@PCPN-treated B16F10 cells with NIR laser irradiation
was further reduced. Furthermore, based on the cytotoxicity data (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>d), the IR780 concentration
needed to achieve a 50% inhibition of cell growth (IC<sub>50</sub> value) for IR780@PCPNs at pH 6.5, estimated to be 1.32 &#x003bc;M,
is appreciably 3.6 times lower compared to that (4.69 &#x003bc;M) of
the counterparts at pH 7.4. This suggests that the acidity-triggered
PEG detachment of IR780@PCPNs could further promote their cellular
uptake to increase intracellular IR780 delivery, thus eliciting cell
death upon NIR-activated <sup>1</sup>O<sub>2</sub> production and
hyperthermia. It should be highlighted that the IC<sub>50</sub> of
IR780@PCPNs at pH 6.5 is somewhat lower than that (2.74 &#x003bc;M)
of free IR780, illustrating the anticancer potency of IR780@PCPNs
superior to free IR780 due to the promoted intracellular IR780 delivery,
photothermal effect, and stability of IR780 molecules. On the other
hand, without NIR laser irradiation, the healthy WS1 cells incubated
with free IR780, PCPNs, and IR780@PCPNs, respectively, showed high
viability (over 90%) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">Figure S14</ext-link>). This
signifies that the IR780@PCPNs have little cytotoxicity on the normal
cells without laser irradiation. According to the above results, the
NIR-triggered PTT and PDT delivered by IR780@PCPNs are expected to
selectively kill cancer cells and reduce the adverse effect on normal
cells.</p></sec></sec><sec id="sec4"><label>4</label><title>Conclusions</title><p>To realize
effective melanoma treatment by amplifying the anticancer
effect of the combined PTT and PDT, in this work, the acidity-triggered
PEG detachable PCPNs composed of a PDA core surrounded by PEGylated
chitosan were developed as IR780 carriers. The IR780@PCPNs exhibited
a mean hydrodynamic diameter of ca. 166.9 nm and a solid-like spherical
shape. Through the acidity-activated cleavage of benzoic imine, the
PEG segments were detached from the IR780@PCPNs, exposing a positively
charged surface. Furthermore, the IR780@PCPNs showed accelerated IR780
release in response to a pH reduction from 7.4 to 5.0. Compared to
free IR780 molecules, the IR780@PCPNs displayed superior photothermal
conversion efficiency, colloidal stability, and photothermal stability.
Also, IR780@PCPNs mediate the depletion of GSH by the Michael addition
between PDA and GSH and produce <sup>1</sup>O<sub>2</sub> under NIR
laser irradiation. Notably, under a culture condition of pH 6.5, imitating
an acidic tumor microenvironment, the internalization of IR780@PCPNs
by B16F10 melanoma cells was efficiently promoted via acidity-triggered
dePEGylation. With NIR laser irradiation, the endocytosed IR780@PCPNs
generated hyperthermia and sufficient <sup>1</sup>O<sub>2</sub> to
disrupt mitochondria, thus killing cancer cells. In conclusion, the
developed IR780@PCPNs showed promoted cellular uptake by acidity-triggered
dePEGylation, thus amplifying the anticancer efficacy of combined
PDT and PTT on melanoma cells. This may provide a meaningful strategy
for future clinical melanoma treatment.</p></sec></body><back><notes id="notes2" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsabm.5c00144?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsabm.5c00144</ext-link>.<list id="silist" list-type="simple"><list-item><p>Synthetic pathway of benzoic
imine-containing PEGylated
chitosan adducts, photos of the aqueous solutions containing bare
PDA particles and PCPNs, respectively, N 1s XPS spectrum of PDA, TGA
profiles of PEGylated chitosan adducts, PDA particles, and PCPNs,
Berry plot for <italic>R</italic><sub>g</sub> and angle-dependent
correlation function of <italic>R</italic><sub>h</sub> of PCPNs in
pH 7.4 PBS, particle size distribution profiles of PCPNs dispersed
in pH 7.4 PBS or 10% FBS-containing pH 7.4 PBS for various time intervals,
particle size distribution profiles of IR780@PCPNs dispersed in pH
7.4 PBS and pH 5.0 acetate buffer for 48 h, particle size distribution
profiles of IR780@PCPNs dispersed in pH 7.4 PBS for different time
intervals, temperature change of PCPN solution for single laser on/off
cycle, temperature elevation profiles of IR780@PCPNs with different
concentrations in PBS exposed to laser irradiation and IR780@PCPNs
in pH 7.4 PBS with NIR laser irradiation of different laser power
densities, particle size distribution profiles of IR780@PCPNs dispersed
in pH 7.4 PBS with or without NIR laser irradiation, UV/vis spectra
of DPBF in PCPN solution or IR780 solution receiving laser irradiation
of different irradiation times, UV/vis spectra of DTNB in GSH solution
treated with PCPNs at 37 &#x000b0;C for various time intervals, and viability
of WS1 cells exposed to various formulations without laser irradiation
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acsabm.5c00144/suppl_file/mt5c00144_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mt5c00144_si_001.pdf"><caption><p>mt5c00144_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="COI-statement" id="notes1"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>This work is supported by the National Science and
Technology Council (NSTC 113-2622-E-005-017; NSTC 113-2628-E-005-002
MY3), National Chung Hsing University, Taiwan.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Lara-Vega</surname><given-names>I.</given-names></name>; <name><surname>Vega-L&#x000f3;pez</surname><given-names>A.</given-names></name>
<article-title>Combinational Photodynamic and Photothermal-Based Therapies
for Melanoma in Mouse Models</article-title>. <source>Photodiagnosis
Photodyn. Ther.</source>
<year>2023</year>, <volume>43</volume>, <elocation-id>103596</elocation-id><pub-id pub-id-type="doi">10.1016/j.pdpdt.2023.103596</pub-id>.<pub-id pub-id-type="pmid">37148952</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Li</surname><given-names>X. Y.</given-names></name>; <name><surname>Tan</surname><given-names>L. C.</given-names></name>; <name><surname>Dong</surname><given-names>L. W.</given-names></name>; <name><surname>Zhang</surname><given-names>W. Q.</given-names></name>; <name><surname>Shen</surname><given-names>X. X.</given-names></name>; <name><surname>Lu</surname><given-names>X.</given-names></name>; <name><surname>Zheng</surname><given-names>H.</given-names></name>; <name><surname>Lu</surname><given-names>Y. G.</given-names></name>
<article-title>Susceptibility
and Resistance Mechanisms
During Photodynamic Therapy of Melanoma</article-title>. <source>Front.
Oncol.</source>
<year>2020</year>, <volume>10</volume>, <fpage>597</fpage><pub-id pub-id-type="doi">10.3389/fonc.2020.00597</pub-id>.<pub-id pub-id-type="pmid">32528867</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Ara&#x000fa;jo</surname><given-names>J. L.</given-names></name>; <name><surname>da Silva</surname><given-names>P. B.</given-names></name>; <name><surname>Fonseca-Santos</surname><given-names>B.</given-names></name>; <name><surname>B&#x000e1;o</surname><given-names>S. N.</given-names></name>; <name><surname>Chorilli</surname><given-names>M.</given-names></name>; <name><surname>de Souza</surname><given-names>P. E. N.</given-names></name>; <name><surname>Muehlmann</surname><given-names>L. A.</given-names></name>; <name><surname>Azevedo</surname><given-names>R. B.</given-names></name>
<article-title>Photodynamic Therapy Directed to Melanoma Skin Cancer
by Thermosensitive Hydrogel Containing Chlorophyll A</article-title>. <source>Pharmaceuticals (Basel)</source>
<year>2023</year>, <volume>16</volume>, <fpage>1659</fpage><pub-id pub-id-type="doi">10.3390/ph16121659</pub-id>.<pub-id pub-id-type="pmid">38139786</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Akasov</surname><given-names>R. A.</given-names></name>; <name><surname>Sholina</surname><given-names>N. V.</given-names></name>; <name><surname>Khochenkov</surname><given-names>D. A.</given-names></name>; et al. <article-title>Photodynamic Therapy
of Melanoma by Blue-Light Photoactivation of Flavin Mononucleotide</article-title>. <source>Sci. Rep.</source>
<year>2019</year>, <volume>9</volume>, <fpage>9679</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-46115-w</pub-id>.<pub-id pub-id-type="pmid">31273268</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Chen</surname><given-names>D. J.</given-names></name>; <name><surname>Li</surname><given-names>X. S.</given-names></name>; <name><surname>Zhao</surname><given-names>H.</given-names></name>; <name><surname>Fu</surname><given-names>Y.</given-names></name>; <name><surname>Kang</surname><given-names>H. R.</given-names></name>; <name><surname>Yao</surname><given-names>F. F.</given-names></name>; et al. <article-title>Dinitrophenyl Hapten
with Laser Immunotherapy for Advanced
Malignant Melanoma: A Clinical Study</article-title>. <source>Oncol.
Lett.</source>
<year>2017</year>, <volume>13</volume>, <fpage>1425</fpage>&#x02013;<lpage>1431</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2016.5530</pub-id>.<pub-id pub-id-type="pmid">28454272</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Bian</surname><given-names>Q.</given-names></name>; <name><surname>Huang</surname><given-names>L.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Gu</surname><given-names>Y.</given-names></name>; <name><surname>Yuan</surname><given-names>A.</given-names></name>; <name><surname>Ma</surname><given-names>X.</given-names></name>; <name><surname>Hu</surname><given-names>J.</given-names></name>; <name><surname>Rao</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Gao</surname><given-names>J.</given-names></name>
<article-title>A Facile Low-Dose
Photosensitizer-Incorporated
Dissolving Microneedles-Based Composite System for Eliciting Antitumor
Immunity and the Abscopal Effect</article-title>. <source>ACS Nano</source>
<year>2021</year>, <volume>15</volume>, <fpage>19468</fpage>&#x02013;<lpage>19479</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.1c06225</pub-id>.<pub-id pub-id-type="pmid">34859990</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>He</surname><given-names>G.</given-names></name>; <name><surname>Fu</surname><given-names>L. H.</given-names></name>; <name><surname>Younis</surname><given-names>M. R.</given-names></name>; <name><surname>He</surname><given-names>T.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Lin</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Huang</surname><given-names>P.</given-names></name>
<article-title>A Microneedle Patch with Self-Oxygenation
and Glutathione Depletion for Repeatable Photodynamic Therapy</article-title>. <source>ACS Nano</source>
<year>2022</year>, <volume>16</volume>, <fpage>17298</fpage>&#x02013;<lpage>17312</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.2c08098</pub-id>.<pub-id pub-id-type="pmid">36166667</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Zhang</surname><given-names>D.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Liang</surname><given-names>G.</given-names></name>; <name><surname>Zheng</surname><given-names>W.</given-names></name>; <name><surname>Gui</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zeng</surname><given-names>W.</given-names></name>; <name><surname>Yang</surname><given-names>Y.</given-names></name>; <name><surname>Zeng</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>Z.</given-names></name>; <name><surname>Fan</surname><given-names>R.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Guan</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Cheng</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Chen</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>J.</given-names></name>; <name><surname>Gong</surname><given-names>M.</given-names></name>
<article-title>Integrated Metabolomics
Revealed the Photothermal Therapy of Melanoma by Mo<sub>2</sub>C Nanosheets:
Toward Rehabilitated Homeostasis in Metabolome Combined Lipidome</article-title>. <source>J. Mater. Chem. B</source>
<year>2024</year>, <volume>12</volume>, <fpage>730</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1039/D3TB02123H</pub-id>.<pub-id pub-id-type="pmid">38165726</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Weng</surname><given-names>B.</given-names></name>; <name><surname>Yang</surname><given-names>H.</given-names></name>; <name><surname>Xiang</surname><given-names>Z.</given-names></name>; <name><surname>Ran</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>C.</given-names></name>
<article-title>Intelligent
Tumor Microenvironment-Activated Multifunctional Nanoplatform Coupled
with Turn-on and Always-on Fluorescence Probes for Imaging-Guided
Cancer Treatment</article-title>. <source>ACS Appl. Mater. Interfaces</source>
<year>2021</year>, <volume>13</volume>, <fpage>53646</fpage>&#x02013;<lpage>53658</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.1c17642</pub-id>.<pub-id pub-id-type="pmid">34748304</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Xiao</surname><given-names>S.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Feng</surname><given-names>M.</given-names></name>; <name><surname>Dong</surname><given-names>M.</given-names></name>; <name><surname>Cao</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>J.</given-names></name>
<article-title>Multifunctional FeS<sub>2</sub> Theranostic
Nanoparticles for Photothermal-Enhanced Chemodynamic/Photodynamic
Cancer Therapy and Photoacoustic Imaging</article-title>. <source>Chem.
Eng. J.</source>
<year>2020</year>, <volume>396</volume>, <elocation-id>125294</elocation-id><pub-id pub-id-type="doi">10.1016/j.cej.2020.125294</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Wei</surname><given-names>L.</given-names></name>; <name><surname>He</surname><given-names>X.</given-names></name>; <name><surname>Liu</surname><given-names>C.</given-names></name>; <name><surname>Kandawa-Shultz</surname><given-names>M.</given-names></name>; <name><surname>Shao</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>
<article-title>Biotin-Functionalized
Iridium-Based Nanoparticles as Tumor Targeted Photosensitizers for
Enhanced Oxidative Damage in Tumor Photodynamic Therapy</article-title>. <source>ACS Appl. Nano Mater.</source>
<year>2024</year>, <volume>7</volume> (<issue>1</issue>), <fpage>1170</fpage>&#x02013;<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1021/acsanm.3c05145</pub-id>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Thankachan</surname><given-names>D.</given-names></name>; <name><surname>Anbazhagan</surname><given-names>R.</given-names></name>; <name><surname>Tsai</surname><given-names>H. C.</given-names></name>; <name><surname>Dinh</surname><given-names>V. T. T.</given-names></name>; <name><surname>Gebrie</surname><given-names>H. T.</given-names></name>; <name><surname>Kitaw</surname><given-names>S. L.</given-names></name>; <name><surname>Ahmed</surname><given-names>Y. W.</given-names></name>; <name><surname>Anley</surname><given-names>B. E.</given-names></name>; <name><surname>Liao</surname><given-names>Y. S.</given-names></name>; <name><surname>Chen</surname><given-names>W. L.</given-names></name>; <name><surname>Chen</surname><given-names>J. K.</given-names></name>
<article-title>Enhanced Tumor Targeting with Near-Infrared
Light-Activated Indocyanine Green Encapsulated in Covalent Organic
Framework for Combined Photodynamic therapy (PDT) and Photothermal
therapy (PTT)</article-title>. <source>Dyes Pigm.</source>
<year>2024</year>, <volume>221</volume>, <elocation-id>111812</elocation-id><pub-id pub-id-type="doi">10.1016/j.dyepig.2023.111812</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Deng</surname><given-names>X.</given-names></name>; <name><surname>Shao</surname><given-names>Z.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>
<article-title>Solutions
to the Drawbacks of Photothermal
and Photodynamic Cancer Therapy</article-title>. <source>Adv. Sci.</source>
<year>2021</year>, <volume>8</volume>, <elocation-id>2002504</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202002504</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Xie</surname><given-names>Z.</given-names></name>; <name><surname>Fan</surname><given-names>T.</given-names></name>; <name><surname>An</surname><given-names>J.</given-names></name>; <name><surname>Choi</surname><given-names>W.</given-names></name>; <name><surname>Duo</surname><given-names>Y.</given-names></name>; <name><surname>Ge</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>B.</given-names></name>; <name><surname>Nie</surname><given-names>G.</given-names></name>; <name><surname>Xie</surname><given-names>N.</given-names></name>; <name><surname>Zheng</surname><given-names>T.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Kim</surname><given-names>J. S.</given-names></name>
<article-title>Emerging Combination
Strategies with Phototherapy in Cancer Nanomedicine</article-title>. <source>Chem. Soc. Rev.</source>
<year>2020</year>, <volume>49</volume>, <fpage>8065</fpage>&#x02013;<lpage>8087</lpage>. <pub-id pub-id-type="doi">10.1039/D0CS00215A</pub-id>.<pub-id pub-id-type="pmid">32567633</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Kong</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>
<article-title>Combined Photodynamic and Photothermal Therapy and Immunotherapy
for Cancer Treatment: A Review</article-title>. <source>Int. J. Nanomedicine</source>
<year>2022</year>, <volume>17</volume>, <fpage>6427</fpage>&#x02013;<lpage>6446</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S388996</pub-id>.<pub-id pub-id-type="pmid">36540374</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Urazaliyeva</surname><given-names>A.</given-names></name>; <name><surname>Kanabekova</surname><given-names>P.</given-names></name>; <name><surname>Beisenbayev</surname><given-names>A.</given-names></name>; <name><surname>Kulsharova</surname><given-names>G.</given-names></name>; <name><surname>Atabaev</surname><given-names>T.</given-names></name>; <name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Lim</surname><given-names>C. K.</given-names></name>
<article-title>All Organic Nanomedicine
for PDT-PTT Combination Therapy of Cancer Cells in Hypoxia</article-title>. <source>Sci. Rep.</source>
<year>2024</year>, <volume>14</volume>, <fpage>17507</fpage><pub-id pub-id-type="doi">10.1038/s41598-024-68077-4</pub-id>.<pub-id pub-id-type="pmid">39080400</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Chen</surname><given-names>Y. H.</given-names></name>; <name><surname>Liu</surname><given-names>I. J.</given-names></name>; <name><surname>Lin</surname><given-names>T. C.</given-names></name>; <name><surname>Tsai</surname><given-names>M. C.</given-names></name>; <name><surname>Hu</surname><given-names>S. H.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Wu</surname><given-names>Y. T.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>PEGylated
Chitosan-Coated Nanophotosensitizers for Effective Cancer Treatment
by Photothermal-Photodynamic Therapy Combined with Glutathione Depletion</article-title>. <source>Int. J. Biol. Macromol.</source>
<year>2024</year>, <volume>266</volume>, <elocation-id>131359</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.131359</pub-id>.<pub-id pub-id-type="pmid">38580018</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Su</surname><given-names>M.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Yang</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Feng</surname><given-names>J.</given-names></name>; <name><surname>Jia</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>Z.</given-names></name>
<article-title>Camptothecin-Loaded
and IR780-Doped Polydopamine Nanomedicine Used for Multifunctional
Chemo-Photothermal-Photodynamic Therapy for Lung Cancer</article-title>. <source>J. Drug Delivery Technol.</source>
<year>2024</year>, <volume>97</volume>, <elocation-id>105657</elocation-id><pub-id pub-id-type="doi">10.1016/j.jddst.2024.105657</pub-id>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Nirmal</surname><given-names>G. R.</given-names></name>; <name><surname>Lin</surname><given-names>Z. C.</given-names></name>; <name><surname>Lin</surname><given-names>C. H.</given-names></name>; <name><surname>Sung</surname><given-names>C. T.</given-names></name>; <name><surname>Liao</surname><given-names>C. C.</given-names></name>; <name><surname>Fang</surname><given-names>J. Y.</given-names></name>
<article-title>Polydopamine/IR820
Nanoparticles as Topical Phototheranostics
for Inhibiting Psoriasiform Lesions Through Dual Photothermal and
Photodynamic Treatments</article-title>. <source>Biomater Sci.</source>
<year>2022</year>, <volume>10</volume>, <fpage>6172</fpage>&#x02013;<lpage>6189</lpage>. <pub-id pub-id-type="doi">10.1039/D2BM00835A</pub-id>.<pub-id pub-id-type="pmid">36073349</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Bao</surname><given-names>J.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>Y.</given-names></name>
<article-title>Design and Construction
of IR780- and EGCG-Based and Mitochondrial Targeting Nanoparticles
and Their Application in Tumor Chemo-Phototherapy</article-title>. <source>J. Mater. Chem. B</source>
<year>2021</year>, <volume>9</volume>, <fpage>9932</fpage>&#x02013;<lpage>9945</lpage>. <pub-id pub-id-type="doi">10.1039/D1TB01899J</pub-id>.<pub-id pub-id-type="pmid">34842269</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Hu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Long</surname><given-names>Q.</given-names></name>; <name><surname>Bai</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>; <name><surname>Jiang</surname><given-names>M.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Mao</surname><given-names>J.</given-names></name>; <name><surname>Zheng</surname><given-names>Y.</given-names></name>; <name><surname>Gao</surname><given-names>Z.</given-names></name>
<article-title>A Self-Assembly ICG Nanoparticle
Potentiating Targeted Photothermal and Photodynamic Therapy in NSCLC</article-title>. <source>ACS Biomater. Sci. Eng.</source>
<year>2022</year>, <volume>8</volume>, <fpage>4535</fpage>&#x02013;<lpage>4546</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.2c00620</pub-id>.<pub-id pub-id-type="pmid">36070516</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Lei</surname><given-names>L.</given-names></name>; <name><surname>Dai</surname><given-names>W.</given-names></name>; <name><surname>Man</surname><given-names>J.</given-names></name>; <name><surname>Hu</surname><given-names>H.</given-names></name>; <name><surname>Jin</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>B.</given-names></name>; <name><surname>Tang</surname><given-names>Z.</given-names></name>
<article-title>Lonidamine Liposomes
to Enhance Photodynamic and Photothermal Therapy
of Hepatocellular Carcinoma by Inhibiting Glycolysis</article-title>. <source>J. Nanobiotechnol.</source>
<year>2023</year>, <volume>21</volume>, <fpage>482</fpage><pub-id pub-id-type="doi">10.1186/s12951-023-02260-z</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Shi</surname><given-names>Y.</given-names></name>; <name><surname>Jiang</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Rashid</surname><given-names>H.</given-names></name>; <name><surname>Yuan</surname><given-names>M.</given-names></name>; <name><surname>Liu</surname><given-names>X.</given-names></name>
<article-title>Advances in Liposomes Loaded with
Photoresponse Materials for Cancer Therapy</article-title>. <source>Biomed. Pharmacother.</source>
<year>2024</year>, <volume>174</volume>, <elocation-id>116586</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2024.116586</pub-id>.<pub-id pub-id-type="pmid">38626516</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Qin</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>M.</given-names></name>; <name><surname>Huang</surname><given-names>C.</given-names></name>; <name><surname>Perry</surname><given-names>H. L.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhu</surname><given-names>D.</given-names></name>
<article-title>O<sub>2</sub>-Generating
Multifunctional Polymeric Micelles for Highly
Efficient and Selective Photodynamic-Photothermal Therapy in Melanoma</article-title>. <source>Chin. Chem. Lett.</source>
<year>2024</year>, <volume>35</volume>, <elocation-id>109171</elocation-id><pub-id pub-id-type="doi">10.1016/j.cclet.2023.109171</pub-id>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Sun</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>He</surname><given-names>W. H. Z.</given-names></name>; <name><surname>Xie</surname><given-names>C.</given-names></name>; <name><surname>Lu</surname><given-names>F.</given-names></name>; <name><surname>Fan</surname><given-names>Q.</given-names></name>
<article-title>Development of Mesoporous
Silica-Based Nanoparticles for Cancer Phototherapy</article-title>. <source>Dyes Pigments</source>
<year>2024</year>, <volume>222</volume>, <elocation-id>111881</elocation-id><pub-id pub-id-type="doi">10.1016/j.dyepig.2023.111881</pub-id>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Jian</surname><given-names>W. H.</given-names></name>; <name><surname>Yu</surname><given-names>T. W.</given-names></name>; <name><surname>Chen</surname><given-names>C. J.</given-names></name>; <name><surname>Huang</surname><given-names>W. C.</given-names></name>; <name><surname>Chiu</surname><given-names>H. C.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Indocyanine Green-Encapsulated Hybrid
Polymeric Nanomicelles
for Photothermal Cancer Therapy</article-title>. <source>Langmuir</source>
<year>2015</year>, <volume>31</volume>, <fpage>6202</fpage>&#x02013;<lpage>6210</lpage>. <pub-id pub-id-type="doi">10.1021/acs.langmuir.5b00963</pub-id>.<pub-id pub-id-type="pmid">25985856</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Park</surname><given-names>T.</given-names></name>; <name><surname>Lee</surname><given-names>S.</given-names></name>; <name><surname>Amatya</surname><given-names>R.</given-names></name>; <name><surname>Cheong</surname><given-names>H.</given-names></name>; <name><surname>Moon</surname><given-names>C.</given-names></name>; <name><surname>Kwak</surname><given-names>H. D.</given-names></name>; <name><surname>Min</surname><given-names>K. A.</given-names></name>; <name><surname>Shin</surname><given-names>M. C.</given-names></name>
<article-title>ICG-Loaded PEGylated BSA-Silver Nanoparticles
for Effective Photothermal Cancer Therapy</article-title>. <source>Int.
J. Nanomedicine</source>
<year>2020</year>, <volume>15</volume>, <fpage>5459</fpage>&#x02013;<lpage>5471</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S255874</pub-id>.<pub-id pub-id-type="pmid">32801700</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>G.</given-names></name>; <name><surname>Ma</surname><given-names>J.</given-names></name>; <name><surname>Lin</surname><given-names>J.</given-names></name>; <name><surname>Lin</surname><given-names>H.</given-names></name>; <name><surname>Su</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>D.</given-names></name>; <name><surname>Ye</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Hou</surname><given-names>Z.</given-names></name>
<article-title>Chemotherapeutic Drug-Photothermal Agent Co-Self-Assembling Nanoparticles
for Near-Infrared Fluorescence and Photoacoustic Dual-Modal Imaging-Guided
Chemo-Photothermal Synergistic Therapy</article-title>. <source>J. Controlled
Release</source>
<year>2017</year>, <volume>258</volume>, <fpage>95</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2017.05.011</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Wang</surname><given-names>T. H.</given-names></name>; <name><surname>Shen</surname><given-names>M. Y.</given-names></name>; <name><surname>Yeh</surname><given-names>N. T.</given-names></name>; <name><surname>Chen</surname><given-names>Y. H.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Chin</surname><given-names>H. Y.</given-names></name>; <name><surname>Wu</surname><given-names>Y. T.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Photothermal
Nanozymes to Self-Augment Combination Cancer Therapy by Dual-Glutathione
Depletion and Hyperthermia/Acidity-Activated Hydroxyl Radical Generation</article-title>. <source>J. Colloid Interface Sci.</source>
<year>2023</year>, <volume>650</volume>, <fpage>1698</fpage>&#x02013;<lpage>1714</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2023.07.134</pub-id>.<pub-id pub-id-type="pmid">37499626</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Shen</surname><given-names>M. Y.</given-names></name>; <name><surname>Chen</surname><given-names>Y. H.</given-names></name>; <name><surname>Yeh</surname><given-names>N. T.</given-names></name>; <name><surname>Wang</surname><given-names>T. H.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Acidity/Hydrogen
Peroxide-Responsive PEGylated Chitosan-Modified Polydopamine Nanoparticles
to Realize Effective Photothermal Conversion and Intracellular Drug
Delivery</article-title>. <source>Eur. Polym. J.</source>
<year>2023</year>, <volume>197</volume>, <elocation-id>112365</elocation-id><pub-id pub-id-type="doi">10.1016/j.eurpolymj.2023.112365</pub-id>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Ren</surname><given-names>Z.</given-names></name>; <name><surname>Liao</surname><given-names>T.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Kuang</surname><given-names>Y.</given-names></name>
<article-title>Drug Delivery Systems
with a &#x02033;Tumor-Triggered&#x02033; Targeting or Intracellular
Drug Release Property Based on DePEGylation</article-title>. <source>Materials (Basel)</source>
<year>2022</year>, <volume>15</volume>, <fpage>5290</fpage><pub-id pub-id-type="doi">10.3390/ma15155290</pub-id>.<pub-id pub-id-type="pmid">35955225</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Tang</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>C.</given-names></name>; <name><surname>Yu</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>K.</given-names></name>; <name><surname>Zheng</surname><given-names>Z.</given-names></name>; <name><surname>Gu</surname><given-names>X.</given-names></name>; <name><surname>Yu</surname><given-names>Q.</given-names></name>; <name><surname>Xu</surname><given-names>F. J.</given-names></name>; <name><surname>Gan</surname><given-names>Z.</given-names></name>
<article-title>Cascade-Responsive
Nano-assembly for Efficient Photothermal-Chemo
Synergistic Inhibition of Tumor Metastasis by Targeting Cancer Stem
Cells</article-title>. <source>Biomaterials</source>
<year>2022</year>, <volume>280</volume>, <elocation-id>121305</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.121305</pub-id>.<pub-id pub-id-type="pmid">34890970</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Li</surname><given-names>P.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Cheng</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Xiao</surname><given-names>J.</given-names></name>; <name><surname>Duan</surname><given-names>X.</given-names></name>
<article-title>Hypoxia-Responsive
Liposome Enhances Intracellular Delivery of Photosensitizer
for Effective Photodynamic Therapy</article-title>. <source>J. Controlled
Release</source>
<year>2025</year>, <volume>377</volume>, <fpage>277</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2024.11.032</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Xue</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>Y.</given-names></name>; <name><surname>Bo</surname><given-names>R.</given-names></name>; <name><surname>Jia</surname><given-names>B.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Yuan</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Ma</surname><given-names>Z.</given-names></name>; <name><surname>Jing</surname><given-names>D.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>; <name><surname>Yu</surname><given-names>W.</given-names></name>; <name><surname>Lin</surname><given-names>T. Y.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>
<article-title>Trojan Horse Nanotheranostics
with Dual Transformability and Multifunctionality for Highly Effective
Cancer Treatment</article-title>. <source>Nat. Commun.</source>
<year>2018</year>, <volume>9</volume>, <fpage>3653</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-06093-5</pub-id>.<pub-id pub-id-type="pmid">30194413</pub-id>
</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Cheng</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Shi</surname><given-names>S.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Wei</surname><given-names>B.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>
<article-title>A Sequentially Responsive
Cascade
Nanoplatform for Increasing Chemo-Chemodynamic Therapy</article-title>. <source>Colloids Surf. B Biointerfaces</source>
<year>2023</year>, <volume>222</volume>, <elocation-id>113099</elocation-id><pub-id pub-id-type="doi">10.1016/j.colsurfb.2022.113099</pub-id>.<pub-id pub-id-type="pmid">36584448</pub-id>
</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Hsieh</surname><given-names>M. H.</given-names></name>; <name><surname>Wang</surname><given-names>T. H.</given-names></name>; <name><surname>Hu</surname><given-names>S. H.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Yow</surname><given-names>J. L.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Tumor Site-Specific
PEG Detachment
and Active Tumor Homing of Therapeutic PEGylated Chitosan/Folate-Decorated
Polydopamine Nanoparticles to Augment Antitumor Efficacy of Photothermal/Chemo
Combination Therapy</article-title>. <source>Chem. Eng. J.</source>
<year>2022</year>, <volume>446</volume>, <elocation-id>137243</elocation-id><pub-id pub-id-type="doi">10.1016/j.cej.2022.137243</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Huang</surname><given-names>S. Y.</given-names></name>; <name><surname>Yeh</surname><given-names>N. T.</given-names></name>; <name><surname>Wang</surname><given-names>T. H.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Chin</surname><given-names>H. Y.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Onion-Like
Doxorubicin-Carrying Polymeric
Nanomicelles with Tumor Acidity-Sensitive DePEGylation to Expose Positively-Charged
Chitosan Shell for Enhanced Cancer Chemotherapy</article-title>. <source>Int. J. Biol. Macromol.</source>
<year>2023</year>, <volume>227</volume>, <fpage>925</fpage>&#x02013;<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2022.12.172</pub-id>.<pub-id pub-id-type="pmid">36563808</pub-id>
</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Hong</surname><given-names>W.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>T. T.</given-names></name>; <name><surname>Chen</surname><given-names>Z.</given-names></name>; <name><surname>Yuan</surname><given-names>S.</given-names></name>; <name><surname>Peng</surname><given-names>P.</given-names></name>; <name><surname>Xiao</surname><given-names>M.</given-names></name>; <name><surname>Xu</surname><given-names>L.</given-names></name>
<article-title>Photothermally
Triggered Cytosolic Drug Delivery of Glucose Functionalized Polydopamine
Nanoparticles In Response To Tumor Microenvironment for The GLUT1-Targeting
Chemo-Phototherapy</article-title>. <source>J. Controlled Release</source>
<year>2020</year>, <volume>317</volume>, <fpage>232</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2019.11.031</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Qin</surname><given-names>J.</given-names></name>; <name><surname>Su</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Jiang</surname><given-names>K.</given-names></name>
<article-title>Fenton Chemistry
Activation in Metal-Organic Frameworks for Synergistic Bacteria Eradication</article-title>. <source>Chem. Eng. J.</source>
<year>2024</year>, <volume>497</volume>, <elocation-id>154413</elocation-id><pub-id pub-id-type="doi">10.1016/j.cej.2024.154413</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Smith</surname><given-names>A. E.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>; <name><surname>Kirkland-York</surname><given-names>S. E.</given-names></name>; <name><surname>Savin</surname><given-names>D. A.</given-names></name>; <name><surname>McCormick</surname><given-names>C. L.</given-names></name>
<article-title>&#x0201c;Schizophrenic&#x0201d;
Self-Assembly of Block Copolymers Synthesized via Aqueous RAFT Polymerization:
From Micelles to Vesicles</article-title>. <source>Macromolecules</source>
<year>2010</year>, <volume>43</volume>, <fpage>1210</fpage>&#x02013;<lpage>1217</lpage>. <pub-id pub-id-type="doi">10.1021/ma902378k</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Sprouse</surname><given-names>D.</given-names></name>; <name><surname>Jiang</surname><given-names>Y.</given-names></name>; <name><surname>Laaser</surname><given-names>J. E.</given-names></name>; <name><surname>Lodge</surname><given-names>T. P.</given-names></name>; <name><surname>Reineke</surname><given-names>T. M.</given-names></name>
<article-title>Tuning
Cationic Block Copolymer Micelle Size by pH and Ionic Strength</article-title>. <source>Biomacromolecules</source>
<year>2016</year>, <volume>17</volume>, <fpage>2849</fpage>&#x02013;<lpage>2859</lpage>. <pub-id pub-id-type="doi">10.1021/acs.biomac.6b00654</pub-id>.<pub-id pub-id-type="pmid">27487088</pub-id>
</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Tian</surname><given-names>Y.</given-names></name>; <name><surname>Younis</surname><given-names>M. R.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>; <name><surname>Liao</surname><given-names>X.</given-names></name>; <name><surname>He</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Teng</surname><given-names>Z.</given-names></name>; <name><surname>Huang</surname><given-names>P.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Lu</surname><given-names>G.</given-names></name>
<article-title>Dye-Loaded Mesoporous Polydopamine Nanoparticles for Multimodal Tumor
Theranostics with Enhanced Immunogenic Cell Death</article-title>. <source>J. Nanobiotechnol.</source>
<year>2021</year>, <volume>19</volume>, <fpage>365</fpage><pub-id pub-id-type="doi">10.1186/s12951-021-01109-7</pub-id>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Liu</surname><given-names>Y. L.</given-names></name>; <name><surname>Wang</surname><given-names>T. H.</given-names></name>; <name><surname>Yeh</surname><given-names>N. T.</given-names></name>; <name><surname>Huang</surname><given-names>W. J.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Wu</surname><given-names>I. T.</given-names></name>; <name><surname>Chin</surname><given-names>H. Y.</given-names></name>; <name><surname>Hu</surname><given-names>S. H.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Tumor-Activated
Targetable Photothermal Chemotherapy
Using IR780/Zoledronic Acid-Containing Hybrid Polymeric Nanoassemblies
with Folate Modification to Treat Aggressive Breast Cancer</article-title>. <source>Nanoscale</source>
<year>2024</year>, <volume>16</volume>, <fpage>1415</fpage>&#x02013;<lpage>1427</lpage>. <pub-id pub-id-type="doi">10.1039/D3NR05637F</pub-id>.<pub-id pub-id-type="pmid">38167914</pub-id>
</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Shao</surname><given-names>N.</given-names></name>; <name><surname>Qi</surname><given-names>Y.</given-names></name>; <name><surname>Lu</surname><given-names>H.</given-names></name>; <name><surname>He</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>B.</given-names></name>; <name><surname>Huang</surname><given-names>Y.</given-names></name>
<article-title>Photostability
Highly Improved Nanoparticles Based on IR-780 and Negative Charged
Copolymer for Enhanced Photothermal Therapy</article-title>. <source>ACS Biomater. Sci. Eng.</source>
<year>2019</year>, <volume>5</volume>, <fpage>795</fpage>&#x02013;<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1021/acsbiomaterials.8b01558</pub-id>.<pub-id pub-id-type="pmid">33405840</pub-id>
</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Mo</surname><given-names>Z.</given-names></name>; <name><surname>Qiu</surname><given-names>M.</given-names></name>; <name><surname>Zhao</surname><given-names>K.</given-names></name>; <name><surname>Hu</surname><given-names>H.</given-names></name>; <name><surname>Xu</surname><given-names>Q.</given-names></name>; <name><surname>Cao</surname><given-names>J.</given-names></name>; <name><surname>Luo</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Xu</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>C.</given-names></name>; <name><surname>Xiong</surname><given-names>Z.</given-names></name>; <name><surname>Liao</surname><given-names>G.</given-names></name>; <name><surname>Yang</surname><given-names>S.</given-names></name>
<article-title>Multifunctional
Phototheranostic
Nanoplatform Based on Polydopamine-Manganese Dioxide-IR780 Iodide
for Effective Magnetic Resonance Imaging-Guided Synergistic Photodynamic/Photothermal
Therapy</article-title>. <source>J. Colloid Interface Sci.</source>
<year>2022</year>, <volume>611</volume>, <fpage>193</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2021.12.071</pub-id>.<pub-id pub-id-type="pmid">34953455</pub-id>
</mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Hu</surname><given-names>D.</given-names></name>; <name><surname>Zhong</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Qu</surname><given-names>Y.</given-names></name>; <name><surname>Liu</surname><given-names>Q.</given-names></name>; <name><surname>Han</surname><given-names>R.</given-names></name>; <name><surname>Yuan</surname><given-names>L.</given-names></name>; <name><surname>Shi</surname><given-names>K.</given-names></name>; <name><surname>Peng</surname><given-names>J.</given-names></name>; <name><surname>Qian</surname><given-names>Z.</given-names></name>
<article-title>Perfluorocarbon-Loaded and Redox-Activatable
Photosensitizing Agent
with Oxygen Supply for Enhancement of Fluorescence/Photoacoustic Imaging
Guided Tumor Photodynamic Therapy</article-title>. <source>Adv. Funct.
Mater.</source>
<year>2019</year>, <volume>29</volume>, <elocation-id>1806199</elocation-id><pub-id pub-id-type="doi">10.1002/adfm.201806199</pub-id>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>He</surname><given-names>D.</given-names></name>; <name><surname>Hai</surname><given-names>L.</given-names></name>; <name><surname>He</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>H. W.</given-names></name>
<article-title>Glutathione-Activatable
and O<sub>2</sub>/Mn<sup>2+</sup>-Evolving Nanocomposite for Highly
Efficient and Selective Photodynamic and Gene-Silencing Dual Therapy</article-title>. <source>Adv. Funct. Mater.</source>
<year>2017</year>, <volume>27</volume>, <elocation-id>1704089</elocation-id><pub-id pub-id-type="doi">10.1002/adfm.201704089</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Liang</surname><given-names>K. A.</given-names></name>; <name><surname>Chih</surname><given-names>H. Y.</given-names></name>; <name><surname>Liu</surname><given-names>I. J.</given-names></name>; <name><surname>Yeh</surname><given-names>N. T.</given-names></name>; <name><surname>Hsu</surname><given-names>T. C.</given-names></name>; <name><surname>Chin</surname><given-names>H. Y.</given-names></name>; <name><surname>Tzang</surname><given-names>B. S.</given-names></name>; <name><surname>Chiang</surname><given-names>W. H.</given-names></name>
<article-title>Tumor-Targeted Delivery
of Hyaluronic Acid/Polydopamine-Coated Fe<sup>2+</sup>-Doped Nano-Scaled
Metal-Organic Frameworks with Doxorubicin Payload for Glutathione
Depletion-Amplified Chemodynamic-Chemo Cancer Therapy</article-title>. <source>J. Colloid Interface Sci.</source>
<year>2025</year>, <volume>677</volume>, <fpage>400</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcis.2024.07.241</pub-id>.<pub-id pub-id-type="pmid">39096708</pub-id>
</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Xiao</surname><given-names>J.</given-names></name>; <name><surname>Hai</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Gong</surname><given-names>M.</given-names></name>; <name><surname>Wang</surname><given-names>Z.</given-names></name>; <name><surname>Tang</surname><given-names>Z.</given-names></name>; <name><surname>Deng</surname><given-names>L.</given-names></name>; <name><surname>He</surname><given-names>D.</given-names></name>
<article-title>An Ultrasmall Fe<sub>3</sub>O<sub>4</sub>-Decorated Polydopamine
Hybrid Nanozyme Enables
Continuous Conversion of Oxygen into Toxic Hydroxyl Radical via GSH-Depleted
Cascade Redox Reactions for Intensive Wound Disinfection</article-title>. <source>Small</source>
<year>2022</year>, <volume>18</volume>, <elocation-id>2105465</elocation-id><pub-id pub-id-type="doi">10.1002/smll.202105465</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Ding</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Tan</surname><given-names>J.</given-names></name>; <name><surname>Meng</surname><given-names>Q.</given-names></name>; <name><surname>Zheng</surname><given-names>P.</given-names></name>; <name><surname>Ma</surname><given-names>P.</given-names></name>; <name><surname>Lin</surname><given-names>J.</given-names></name>
<article-title>ZIF-8 Nanoparticles
Evoke Pyroptosis for High-Efficiency
Cancer Immunotherapy</article-title>. <source>Angew. Chem., Int. Ed.
Engl.</source>
<year>2023</year>, <volume>62</volume>, <elocation-id>e202215307</elocation-id><pub-id pub-id-type="doi">10.1002/anie.202215307</pub-id>.<pub-id pub-id-type="pmid">36629270</pub-id>
</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Zhu</surname><given-names>X.</given-names></name>; <name><surname>Zheng</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Shen</surname><given-names>X.</given-names></name>; <name><surname>Chen</surname><given-names>Q.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Chen</surname><given-names>K.</given-names></name>; <name><surname>Ai</surname><given-names>S.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Guan</surname><given-names>W.</given-names></name>; <name><surname>Yao</surname><given-names>S.</given-names></name>; <name><surname>Liu</surname><given-names>S.</given-names></name>
<article-title>Enhanced Photodynamic
Therapy Synergizing with Inhibition of Tumor Neutrophil Ferroptosis
Boosts Anti-PD-1 Therapy of Gastric Cancer</article-title>. <source>Adv. Sci.</source>
<year>2024</year>, <volume>11</volume>, <elocation-id>e2307870</elocation-id><pub-id pub-id-type="doi">10.1002/advs.202307870</pub-id>.</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Zhuang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>K.</given-names></name>; <name><surname>Li</surname><given-names>N.</given-names></name>; <name><surname>Zhao</surname><given-names>N.</given-names></name>; <name><surname>Tang</surname><given-names>B. Z.</given-names></name>
<article-title>Efficient
NIR-II Type-I AIE Photosensitizer
for Mitochondria-Targeted Photodynamic Therapy Through Synergistic
Apoptosis-Ferroptosis</article-title>. <source>ACS Nano</source>
<year>2023</year>, <volume>17</volume>, <fpage>9110</fpage>&#x02013;<lpage>9125</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.2c12319</pub-id>.<pub-id pub-id-type="pmid">37144959</pub-id>
</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Ke</surname><given-names>Q.</given-names></name>; <name><surname>Jiang</surname><given-names>K.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>B.</given-names></name>
<article-title>Hierarchically
Micro-, Meso-, and Macro-Porous MOF Nanosystems for Localized Cross-Scale
Dual-Biomolecule Loading and Guest-Carrier Cooperative Anticancer
Therapy</article-title>. <source>ACS Nano</source>
<year>2024</year>, <volume>18</volume>, <fpage>21911</fpage>&#x02013;<lpage>21924</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.4c02288</pub-id>.<pub-id pub-id-type="pmid">39102565</pub-id>
</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Shen</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>X.</given-names></name>; <name><surname>Liang</surname><given-names>L.</given-names></name>; <name><surname>Yue</surname><given-names>J.</given-names></name>; <name><surname>Huang</surname><given-names>D.</given-names></name>; <name><surname>Xu</surname><given-names>W.</given-names></name>; <name><surname>Shi</surname><given-names>W.</given-names></name>; <name><surname>Liang</surname><given-names>C.</given-names></name>; <name><surname>Xu</surname><given-names>S.</given-names></name>
<article-title>Mitochondria-Targeting
Supra-Carbon Dots: Enhanced Photothermal Therapy Selective to Cancer
Cells and Their Hyperthermia Molecular Actions</article-title>. <source>Carbon</source>
<year>2020</year>, <volume>156</volume>, <fpage>558</fpage>&#x02013;<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbon.2019.09.079</pub-id>.</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>He</surname><given-names>X.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Zhao</surname><given-names>Y.</given-names></name>; <name><surname>Lu</surname><given-names>S.</given-names></name>; <name><surname>Peng</surname><given-names>Y.</given-names></name>; <name><surname>Lu</surname><given-names>L.</given-names></name>; <name><surname>Hu</surname><given-names>X.</given-names></name>; <name><surname>Zhan</surname><given-names>M.</given-names></name>
<article-title>Native Mitochondria-Targeting Polymeric
Nanoparticles for Mild Photothermal Therapy Rationally Potentiated
with Immune Checkpoints Blockade to Inhibit Tumor Recurrence and Metastasis</article-title>. <source>Chem. Eng. J.</source>
<year>2021</year>, <volume>424</volume>, <elocation-id>130171</elocation-id><pub-id pub-id-type="doi">10.1016/j.cej.2021.130171</pub-id>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Machado</surname><given-names>M. G. C.</given-names></name>; <name><surname>de Oliveira</surname><given-names>M. A.</given-names></name>; <name><surname>Lanna</surname><given-names>E. G.</given-names></name>; <name><surname>Siqueira</surname><given-names>R. P.</given-names></name>; <name><surname>Pound-Lana</surname><given-names>G.</given-names></name>; <name><surname>Branquinho</surname><given-names>R. T.</given-names></name>; <name><surname>Mosqueira</surname><given-names>V. C. F.</given-names></name>
<article-title>Photodynamic
Therapy with The Dual-Mode Association of IR780 to PEG-PLA Nanocapsules
and The Effects on Human Breast Cancer Cells</article-title>. <source>Biomed. Pharmacother.</source>
<year>2022</year>, <volume>145</volume>, <elocation-id>112464</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2021.112464</pub-id>.<pub-id pub-id-type="pmid">34864313</pub-id>
</mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Zhang</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>T.</given-names></name>; <name><surname>Su</surname><given-names>Y.</given-names></name>; <name><surname>Luo</surname><given-names>S.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Tan</surname><given-names>X.</given-names></name>; <name><surname>Fan</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Zhou</surname><given-names>Y.</given-names></name>; <name><surname>Cheng</surname><given-names>T.</given-names></name>; <name><surname>Shi</surname><given-names>C.</given-names></name>
<article-title>A Near-Infrared
Fluorescent Heptamethine Indocyanine Dye with Preferential Tumor Accumulation
for In Vivo Imaging</article-title>. <source>Biomaterials</source>
<year>2010</year>, <volume>31</volume>, <fpage>6612</fpage>&#x02013;<lpage>6617</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.05.007</pub-id>.<pub-id pub-id-type="pmid">20542559</pub-id>
</mixed-citation></ref></ref-list></back></article>